50 related articles for article (PubMed ID: 8301696)
1. The role of chelation in the treatment of other metal poisonings.
Smith SW
J Med Toxicol; 2013 Dec; 9(4):355-69. PubMed ID: 24113858
[TBL] [Abstract][Full Text] [Related]
2. Aluminium in the Human Brain: Routes of Penetration, Toxicity, and Resulting Complications.
Bryliński Ł; Kostelecka K; Woliński F; Duda P; Góra J; Granat M; Flieger J; Teresiński G; Buszewicz G; Sitarz R; Baj J
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108392
[TBL] [Abstract][Full Text] [Related]
3. Fluorescent N/Al Co-Doped Carbon Dots from Cellulose Biomass for Sensitive Detection of Manganese (VII).
Jayaweera S; Yin K; Hu X; Ng WJ
J Fluoresc; 2019 Nov; 29(6):1291-1300. PubMed ID: 31707509
[TBL] [Abstract][Full Text] [Related]
4. Unequivocal imaging of aluminium in human cells and tissues by an improved method using morin.
Mold MJ; Kumar M; Chu W; Exley C
Histochem Cell Biol; 2019 Dec; 152(6):453-463. PubMed ID: 31463522
[TBL] [Abstract][Full Text] [Related]
5. Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation.
Huat TJ; Camats-Perna J; Newcombe EA; Valmas N; Kitazawa M; Medeiros R
J Mol Biol; 2019 Apr; 431(9):1843-1868. PubMed ID: 30664867
[TBL] [Abstract][Full Text] [Related]
6. Link between Aluminum and the Pathogenesis of Alzheimer's Disease: The Integration of the Aluminum and Amyloid Cascade Hypotheses.
Kawahara M; Kato-Negishi M
Int J Alzheimers Dis; 2011 Mar; 2011():276393. PubMed ID: 21423554
[TBL] [Abstract][Full Text] [Related]
7. Transient proliferation of proanthocyanidin-accumulating cells on the epidermal apex contributes to highly aluminum-resistant root elongation in camphor tree.
Osawa H; Endo I; Hara Y; Matsushima Y; Tange T
Plant Physiol; 2011 Jan; 155(1):433-46. PubMed ID: 21045123
[TBL] [Abstract][Full Text] [Related]
8. Metal ion physiopathology in neurodegenerative disorders.
Bolognin S; Messori L; Zatta P
Neuromolecular Med; 2009; 11(4):223-38. PubMed ID: 19946766
[TBL] [Abstract][Full Text] [Related]
9. Molecular shuttle chelation: the use of ascorbate, desferrioxamine and Feralex-G in combination to remove nuclear bound aluminum.
Kruck TP; Cui JG; Percy ME; Lukiw WJ
Cell Mol Neurobiol; 2004 Jun; 24(3):443-59. PubMed ID: 15206824
[TBL] [Abstract][Full Text] [Related]
10. Interaction of aluminum with PHFtau in Alzheimer's disease neurofibrillary degeneration evidenced by desferrioxamine-assisted chelating autoclave method.
Murayama H; Shin RW; Higuchi J; Shibuya S; Muramoto T; Kitamoto T
Am J Pathol; 1999 Sep; 155(3):877-85. PubMed ID: 10487845
[TBL] [Abstract][Full Text] [Related]
11. Aluminum chelation by 3-hydroxypyridin-4-ones in the rat demonstrated by microdialysis.
Yokel RA
Biol Trace Elem Res; 1996; 53(1-3):193-203. PubMed ID: 8862748
[TBL] [Abstract][Full Text] [Related]
12. Prevention and treatment of aluminum toxicity including chelation therapy: status and research needs.
Yokel RA; Ackrill P; Burgess E; Day JP; Domingo JL; Flaten TP; Savory J
J Toxicol Environ Health; 1996 Aug; 48(6):667-83. PubMed ID: 8772805
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of potential aluminum chelators in vitro by aluminum solubilization ability, aluminum mobilization from transferrin and the octanol/aqueous distribution of the chelators and their complexes with aluminum.
Yokel RA; Datta AK; Jackson EG
J Pharmacol Exp Ther; 1991 Apr; 257(1):100-6. PubMed ID: 2019981
[TBL] [Abstract][Full Text] [Related]
14. The 3-hydroxypyridin-4-ones more effectively chelate aluminum in a rabbit model of aluminum intoxication than does desferrioxamine.
Yokel RA; Meurer KA; Skinner TL; Fredenburg AM
Drug Metab Dispos; 1996 Jan; 24(1):105-11. PubMed ID: 8825197
[TBL] [Abstract][Full Text] [Related]
15. Short-term oral 3-hydroxypyridin-4-one dosing increases aluminum excretion and partially reverses aluminum-induced toxicity in the rabbit independent of chelator lipophilicity.
Yokel RA; Meurer KA; Hong CB; Dickey KM; Skinner TL; Fredenburg AM
Drug Metab Dispos; 1997 Feb; 25(2):182-90. PubMed ID: 9029049
[TBL] [Abstract][Full Text] [Related]
16. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
Giardina PJ; Grady RW
Semin Hematol; 1995 Oct; 32(4):304-12. PubMed ID: 8560288
[TBL] [Abstract][Full Text] [Related]
17. Aluminum chelation: chemistry, clinical, and experimental studies and the search for alternatives to desferrioxamine.
Yokel RA
J Toxicol Environ Health; 1994 Feb; 41(2):131-74. PubMed ID: 8301696
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
